Reached Settlement for Plaintiff in Patent Case Against Eli Lilly and ImClone Related to Cancer Drug

June 28, 2022

THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA v. ELI LILLY et al, 2:15-cv- 06133 (E.D. Pa.)

Robins Kaplan LLP represented the Trustees of the University of Pennsylvania in a complex patent infringement matter against Eli Lilly and ImClone related to the manufacture and sale of Erbitux, a blockbuster cancer drug. Penn asserted a claim of patent infringement for methods of treating cancer with the Defendants’ drug Erbitux followed by radiation. Erbitux is an antibody to EGFR. The case was resolved on confidential terms before trial.

Past results are reported to provide the reader with an indication of the type of litigation we practice. They do not and should not be construed to create an expectation of result in any other case, as all cases are dependent upon their own unique fact situation and applicable law.
Disclaimer

Similar Results

Back to Top